Skip to main content
. 2009 Jan 21;2009(1):CD003595. doi: 10.1002/14651858.CD003595.pub2

9.3. Analysis.

9.3

Comparison 9 HUS studies: Shiga toxin binding agent plus supportive therapy versus placebo plus supportive care, Outcome 3 Proteinuria ≥ 2 at last follow‐up (60 days).